Instead, a long term, eventually lifelong, treatment with nucleos(t)ide analogues (NA) is used to inhibit viral replication in naïve patients with advanced or de-compensated cirrhosis or after IFN-α failure [1,2,3,4]. This evidence concerns the gene IFNA1 and Cirrhosis.